Abiopharma

Clinical trial NCT07712874: start date: 2026-08-03 → 2026-08-04.

Clinical trial NCT06806293: primary completion date: 2026-08-01 → 2026-06-29.

Clinical trial NCT06616194 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-12-02 → 2029-10-13 3. primary completion date: 2026-10-08 → 2028-08-19

Clinical trial NCT05823766: primary completion date: 2026-06-01 → 2026-10-01.

Clinical trial NCT07533942 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-07-16

Clinical trial NCT04626479 updates: 1. completion date: 2026-07-17 → 2026-08-21 2. primary completion date: 2026-07-17 → 2026-08-21

Clinical trial NCT04626518 updates: 1. completion date: 2026-05-31 → 2026-08-21 2. primary completion date: 2026-05-31 → 2026-08-21

Clinical trial NCT07533019: enrollment: 60 → 66 participants.

Clinical trial NCT07174336: enrollment: 920 → 800 participants.

Clinical trial NCT07064564 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-01 → 2026-07-25 3. completion date: 2029-03-31 → 2029-12-31 4. primary completion date: 2027-06-01 → 2029-10-01